Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 28;14(1):30998.
doi: 10.1038/s41598-024-81965-z.

Squamous cell carcinoma predicts worse prognosis in stage IA (≤ 2 cm) non-small cell lung cancer patients following sublobectomy: a population-based study

Jiannan Xu #  1 , Kai Zhang #  1 , Huiguo Chen  1 , Weibin Wu  1 , Xiaojun Li  1 , Yuanheng Huang  1 , Yonghui Wu  2 , Jian Zhang  3
Affiliations

Squamous cell carcinoma predicts worse prognosis in stage IA (≤ 2 cm) non-small cell lung cancer patients following sublobectomy: a population-based study

Jiannan Xu et al. Sci Rep. .

Abstract

Recent studies recommend sublobectomy as a surgical approach for non-small cell lung cancer (NSCLC) tumors that are 2 cm or smaller. However, it remains unclear whether NSCLC patients with squamous cell carcinoma (SCC) have comparable outcomes to those with adenocarcinoma (ADC) following sublobectomy. To that end, this study aims to compare the survival outcomes between SCC and ADC in patients with stage IA NSCLC (≤ 2 cm) who have undergone sublobectomy. We identified stage IA (≤ 2 cm) NSCLC patients diagnosed with lung squamous cell carcinoma or adenocarcinoma pathology and underwent sublobectomy from the Surveillance, Epidemiology, and End Results (SEER) database from 2004 to 2020. Overall survival (OS) was determined using the Kaplan-Meier method, and Cox proportional hazards regression was employed to identify risk factors for OS. A total of 9,831 patients diagnosed with stage IA NSCLC (≤ 2 cm) were evaluated. Of these, 2,078 patients met the inclusion criteria, including 1,565 with adenocarcinoma (ADC) and 513 with squamous cell carcinoma (SCC). Notably, SCC was associated with worse overall survival compared to ADC (HR: 2.02, 95% CI: 1.34-3.05, P = 0.03). Subgroup analyses revealed that SCC was comparable to ADC in terms of OS for tumors ≤ 1 cm (HR: 1.22, 95% CI: 0.47-3.18, P = 0.83), while patients with SCC displayed worse OS compared to ADC for tumors > 1 to 2 cm (HR: 2.05, 95% CI: 1.31-3.23, P = 0.002). Cox proportional hazards regression analysis identified female sex (HR: 1.53, 95% CI: 1.08-2.19, P = 0.017), high tumor grade (HR: 1.76, 95% CI: 1.02-3.03, P = 0.011), and SCC (HR: 1.58, 95% CI: 1.08-2.30, P = 0.017) as independent risk factors for OS. In patients with stage IA (≤ 2 cm) NSCLC who underwent sublobectomy, SCC is associated with worse overall survival compared to ADC. Furthermore, being female, having a high tumor grade, and SCC pathology are independent risk factors for OS in these patients.

Keywords: Adenocarcinoma; Non-small cell lung cancer; Oncologic outcome; Squamous cell carcinoma; Sublobectomy.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
The flow chart of the study selection process.
Fig. 2
Fig. 2
(A) Kaplan-Meier survival curves of overall survival for tumors ≤ 2.0 cm. (B) Kaplan-Meier survival curves of overall survival for tumors ≤ 1.0 cm. (C) Kaplan-Meier survival curves of overall survival for tumors 1–2 cm.
Fig. 3
Fig. 3
(A) Kaplan-Meier survival curves of overall survival for wedge resection. (B) Kaplan-Meier survival curves of overall survival for segmentectomy.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.74 (3), 229–263 (2024). - PubMed
    1. Cahan, W. G. Radical lobectomy. J. Thorac. Cardiovasc. Surg.39, 555–572 (1960). - PubMed
    1. Lardinois, D. et al. ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. Eur. J. Cardiothorac. Surg.30 (5), 787–792 (2006). - PubMed
    1. Li, R. Z. & Qiu, B. JCOG lung cancer surgery trial series: review and interpretation. Zhonghua Zhong Liu Za Zhi44 (7), 703–711 (2022). - PubMed
    1. Suzuki, K. et al. A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer. J. Thorac. Cardiovasc. Surg.163 (1), 289–301e282 (2022). - PubMed

MeSH terms